74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Tecan Group AG
Open
SectorHealthcare
151.2 3.85
Overview
Share price change
24h
Min
145.6
Max
151.9
Income | 22M |
|---|---|
Sales | 467M |
P/E Sector Avg | 26.793 57.333 |
Dividend yield | 2.11 |
Profit margin | 4.808 |
Employees | 3,074 |
EBITDA | 53M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +39.87% upside |
Dividend yield Sector Avg | 2.11% 2.63% |
|---|
Market Cap | 1.8B |
|---|---|
Previous open | 147.35 |
Previous close | 151.2 |
Tecan Group AG Chart
Past performance is not a reliable indicator of future results.
Related News
Tecan Group AG Forecast
Price Target
By TipRanks
39.87% upside
12 Months Forecast
Average 207.003 CHF 39.87%
High 219 CHF
Low 192 CHF
Based on 3 Wall Street analysts offering 12 month price targets forTecan Group AG - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Tecan Group AG
Tecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution. It provides PARAMIT, a contract design and manufacturing service. The company operates in Switzerland, Europe, Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.